TransCode TherapeuticsOffering
TransCode is a pre-clinical biopharmaceutical company focused on the development and commercialization of therapeutics to treat metastatic cancer.
TransCode is a pre-clinical biopharmaceutical company focused on the development and commercialization of therapeutics to treat metastatic cancer.
The capital raising process completed on March 29th. Listing on the OTCQX is planned.